1. Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies
    Ander Abarrategi et al, 2016, Stem Cells International CrossRef
  2. MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2
    Ruyi Zhang et al, 2016, Tumor Biol. CrossRef
  3. Downregulation of microRNA-497 is associated with upregulation of synuclein γ in patients with osteosarcoma
    Liang Wang et al, 2016 CrossRef
  4. Identification of candidate drugs for the treatment of metastatic osteosarcoma through a subpathway analysis method
    Xin Li et al, 2017 CrossRef
  5. Doxorubicin activates the Notch signaling pathway in osteosarcoma
    HONGJUN MEI et al, 2015 CrossRef
  6. Long non-coding RNA THOR promotes human osteosarcoma cell growth in vitro and in vivo
    Wangzhen Chen et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  7. Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21
    Jianhui Zhao et al, 2018, J. Cell. Biochem. CrossRef
  8. Vincristine-loaded hydroxyapatite nanoparticles as a potential delivery system for bone cancer therapy
    Ana Luiza Chaves Maia et al, 2018, Journal of Drug Targeting CrossRef
  9. Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis.
    Binghua Zhou et al, 2018, Biomed Pharmacother CrossRef
  10. Adenovirus-mediated small interfering RNA targeting ezrin induces apoptosis and inhibits metastasis of human osteosarcoma MG-63 cells
    Zhi-Wei Tao et al, 2018, Biosci. Rep. CrossRef
  11. DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways
    Zaid Maayah et al, 2018, Pharmaceutics CrossRef
  12. The possible role of insulin-like growth factor-1 in osteosarcoma
    Yu-sheng Li et al, 2018, Current Problems in Cancer CrossRef
  13. Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts
    Yang Wang et al, 2018, J Exp Clin Cancer Res CrossRef
  14. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in the altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype
    Yao Xiao et al, 2018, Cancer Letters CrossRef
  15. Functionalized Keratin as Nanotechnology-Based Drug Delivery System for the Pharmacological Treatment of Osteosarcoma
    Elisa Martella et al, 2018, IJMS CrossRef
  16. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells
    Liangwei Mei et al, 2019, Cancer Sci CrossRef
  17. Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies
    Ruiling Chen et al, 2019, J Cell Mol Med CrossRef
  18. Metallothionein: Potential therapeutic target for osteosarcoma
    Salma Siddiqui et al, 2019, Journal of Oncological Sciences CrossRef
  19. ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.
    Elizabeth Ann Roundhill et al, 2019, Cancer Lett CrossRef
  20. Role of autophagy in osteosarcoma.
    Olivier Camuzard et al, 2019, J Bone Oncol CrossRef
  21. miRNA signatures in childhood sarcomas and their clinical implications
    G. M. Viera et al, 2019, Clin Transl Oncol CrossRef
  22. null
    Christos Valavanis et al, 2019 CrossRef
  23. Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas.
    Shuhei Osaki et al, 2016, Sci Rep CrossRef
  24. Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma
    Zuozhang Yang et al, 2016, Cell Death Dis CrossRef
  25. MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1
    Xinyu Tan et al, 2015, Bone Res CrossRef
  26. Lack of efficacy of neoadjuvant chemotherapy in adult patients with maxillo-facial high-grade osteosarcomas: A French experience in two reference centers
    Jebrane Bouaoud et al, 2019, Oral Oncology CrossRef
  27. Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway.
    Hongzhi Zhang et al, 2019, Eur J Pharmacol CrossRef
  28. Nomograms predicting overall survival and cancer-specific survival in osteosarcoma patients (STROBE)
    Wenhao Chen et al, 2019, Medicine CrossRef
  29. null
    Luke Tattersall et al, 2019 CrossRef
  30. Mutant p53 gain of function induces HER2 over-expression in cancer cells
    A. A. Román-Rosales et al, 2018, BMC Cancer CrossRef
  31. MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A
    Wen-chao Yu et al, 2019, Biosci. Rep. CrossRef
  32. Osteomimetic matrix components alter cell migration and drug response in a 3D tumour-engineered osteosarcoma model
    M. Pavlou et al, 2019, Acta Biomaterialia CrossRef
  33. In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice
    Maria Eugénia Marques da Costa et al, 2019, Cancers CrossRef
  34. Pediatric Osteosarcoma of Extremities
    Ahmed M. Morsy et al, 2019, Journal of Pediatric Hematology/Oncology CrossRef
  35. Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells.
    Jian Zhu et al, 2019, Cancer Cell Int CrossRef
  36. Onco-epidemiology of domestic animals and targeted therapeutic attempts: perspectives on human oncology
    Alessandro Di Cerbo et al, 2014, J Cancer Res Clin Oncol CrossRef
  37. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma
    Qingbing Meng et al, 2014, Tumor Biol. CrossRef
  38. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells
    Wei Zhang et al, 2015, Tumor Biol. CrossRef
  39. MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1
    Hong Pei et al, 2015, Mol Cell Biochem CrossRef
  40. Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy
    Claudia Maria Hattinger et al, 2015, Histopathology CrossRef
  41. Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal.
    Suoyuan Li et al, 2015, Tumour Biol. CrossRef
  42. MicroRNAs in osteosarcoma
    Jian Zhang et al, 2015, Clinica Chimica Acta CrossRef
  43. The NF-κB pathway is critically implicated in the oncogenic phenotype of human osteosarcoma cells.
    Bingyi Tan et al, 2021, J Appl Biomed CrossRef
  44. Knockdown of ST6Gal-I inhibits the growth and invasion of osteosarcoma MG-63 cells
    Qingtao Meng et al, 2015, Biomedicine & Pharmacotherapy CrossRef
  45. Advances in emerging drugs for osteosarcoma
    Claudia Maria Hattinger et al, 2015, Expert Opinion on Emerging Drugs CrossRef
  46. BMI1 Is Expressed in Canine Osteosarcoma and Contributes to Cell Growth and Chemotherapy Resistance
    Mehdi Hayat Shahi et al, 2015, PLoS ONE CrossRef
  47. Effect of PI3K-mediated autophagy in human osteosarcoma MG63 cells on sensitivity to chemotherapy with cisplatin
    Xu-Dong Miao et al, 2015, Asian Pacific Journal of Tropical Medicine CrossRef
  48. Morphological and Immunohistochemical Characterization of Canine Osteosarcoma Spheroid Cell Cultures
    C. Gebhard et al, 2016, Anat. Histol. Embryol. CrossRef
  49. Prognostic Significance of Survivin Expression in Osteosarcoma Patients: A Meta-Analysis
    Yugang Liu et al, 2015, Med Sci Monit CrossRef
  50. Dual mTORC1/2 inhibition by INK-128 results in antitumor activity in preclinical models of osteosarcoma
    Haibin Jiang et al, 2015, Biochemical and Biophysical Research Communications CrossRef
  51. The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer
    Jian Zhao et al, 2015, BMC Cancer CrossRef
  52. Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1
    Kewei Zhu et al, 2016, Tumor Biol. CrossRef
  53. Fibroblast growth factor receptor 1 promotes MG63 cell proliferation and is associated with increased expression of cyclin-dependent kinase 1 in osteosarcoma
    WEI ZHOU et al, 2016 CrossRef
  54. Twist mediates an aggressive phenotype in human colorectal cancer cells
    JUN-JIAN DENG et al, 2016 CrossRef
  55. Hydrogen bonded and stacked geometries of the temozolomide dimer
    Okuma Emile Kasende et al, 2016, J Mol Model CrossRef
  56. Aloe-emodin-mediated photodynamic therapy induces autophagy and apoptosis in human osteosarcoma cell line MG-63 through the ROS/JNK signaling pathway
    PINGHUA TU et al, 2016 CrossRef
  57. Histone Deacetylase 4 Promotes Osteosarcoma Cell Proliferation and Invasion by Regulating Expression of Proliferating Cell Nuclear Antigen
    Kun Cao et al, 2019, Front. Oncol. CrossRef
  58. Elimination of Osteosarcoma by Necroptosis with Graphene Oxide-Associated Anti-HER2 Antibodies
    Hongmei Xiao et al, 2019, IJMS CrossRef
  59. Fibulin-4 is a novel Wnt/β-Catenin pathway activator in human osteosarcoma
    Renzeng Li et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  60. Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma.
    Zheng-Xuan Liu et al, 2016, Tumour Biol CrossRef
  61. Anticancer effect of thalidomide in vitro on human osteosarcoma cells
    Jianwei Zhu et al, 2016 CrossRef
  62. GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy
    Mihwa Kim et al, 2017, Autophagy CrossRef
  63. Review of Osteosarcoma and Current Management.
    Ryan A Durfee et al, 2016, Rheumatol Ther CrossRef
  64. Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling.
    Yongfei Cao et al, 2017, Eur J Pharmacol CrossRef
  65. Foscan and foslip based photodynamic therapy in osteosarcomain vitroand in intratibial mouse models
    Daniela Meier et al, 2017, Int. J. Cancer CrossRef
  66. Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope
    Marc Garcia-Moure et al, 2017, Journal of Bone Oncology CrossRef
  67. Exosomal MiRNAs in Pediatric Cancers
    Angela Galardi et al, 2019, IJMS CrossRef
  68. Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer
    Jun Yin et al, 2017, PLoS ONE CrossRef
  69. Involvement of c-Fos in cell proliferation, migration, and invasion in osteosarcoma cells accompanied by altered expression of Wnt2 and Fzd9
    Qiaozhen Wang et al, 2017, PLoS ONE CrossRef
  70. MicroRNA-302a suppresses cell proliferation, migration and invasion in osteosarcoma by targeting ADAM9
    Xiaoming Yang et al, 2017 CrossRef
  71. miR-491-3p suppresses the growth and invasion of osteosarcoma cells by targeting TSPAN1.
    Junhu Duan et al, 2017, Mol Med Rep CrossRef
  72. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy
    Dan Chen et al, 2017, Tumour Biol. CrossRef
  73. miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b
    Qing Liu et al, 2019, Cell Cycle CrossRef
  74. PAXX is a novel target to overcome resistance to doxorubicin and cisplatin in osteosarcoma
    Wanli Ma et al, 2019, Biochemical and Biophysical Research Communications CrossRef
  75. Cancer Stem Cells and Osteosarcoma
    Abul Arif et al, 2019, Techniques in Orthopaedics CrossRef
  76. Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells
    Ju Yeon Oh et al, 2019, Cancers CrossRef
  77. The Potential Selective Cytotoxicity of Poly (L- Lactic Acid)-Based Scaffolds Functionalized with Nanohydroxyapatite and Europium (III) Ions toward Osteosarcoma Cells
    Mateusz Sikora et al, 2019, Materials CrossRef
  78. Increased expression of ecotropic viral integration site 2A indicates a poor prognosis and promotes osteosarcoma evolution through activating MEK/ERK pathway
    Shuo Li et al, 2019, Journal of Receptors and Signal Transduction CrossRef
  79. PEG-sheddable reduction-sensitive polyurethane micelles for triggered intracellular drug delivery for osteosarcoma treatment
    Zhengjie Yang et al, 2019, Journal of Orthopaedic Translation CrossRef
  80. Regulation of ATP‐binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer
    Hao Wang et al, 2019, Cancer Sci CrossRef
  81. piR‐39980 promotes cell proliferation, migration and invasion, and inhibits apoptosis via repression of SERPINB1 in human osteosarcoma
    Basudeb Das et al, 2020, Biol. Cell CrossRef
  82. Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities
    Zifeng Song et al, 2020, Sci Rep CrossRef
  83. Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression
    Timothy M. Fan et al, 2020, Front. Oncol. CrossRef
  84. Application of artificial intelligence in modeling of the doxorubicin release behavior of pH and temperature responsive poly(NIPAAm-co-AAc)-PEG IPN hydrogel
    Cihangir Boztepe et al, 2020, Journal of Drug Delivery Science and Technology CrossRef
  85. miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer
    Shuai Wu et al, 2020 CrossRef
  86. MIR600HG suppresses metastasis and enhances oxaliplatin chemosensitivity by targeting ALDH1A3 in colorectal cancer.
    Yi Yao et al, 2020, Biosci Rep CrossRef
  87. Leucine and branched-chain amino acid metabolism contribute to the growth of bone sarcomas by regulating AMPK and mTORC1 signaling
    Shailer B. Martin et al, 2020 CrossRef
  88. The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells
    Loredana Zocchi et al, 2018, Oncotarget CrossRef
  89. Long non-coding RNAs in osteosarcoma
    Ruiling Chen et al, 2017, Oncotarget CrossRef
  90. MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene
    Youguang Pu et al, 2016, Oncotarget CrossRef
  91. Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment
    Jing Li et al, 2016, Oncotarget CrossRef
  92. Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling
    Ling Yu et al, 2016, Oncotarget CrossRef
  93. Selective Activation of ZAK β Expression by 3-Hydroxy-2-Phenylchromone Inhibits Human Osteosarcoma Cells and Triggers Apoptosis via JNK Activation
    Chien-Yao Fu et al, 2020, IJMS CrossRef
  94. ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo
    Gang Yin et al, 2017, Oncotarget CrossRef
  95. Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment
    Lavinia Raimondi et al, 2017, Oncotarget CrossRef
  96. The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models
    Yun-Rong Zhu et al, 2016, Oncotarget CrossRef
  97. miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma
    Meng Xu et al, 2014, Oncotarget CrossRef
  98. CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
    Lin Dong et al, 2020, J Mol Hist CrossRef
  99. Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate
    Feng Wang et al, 2020, Cancer Cell Int CrossRef
  100. Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma
    Martina Godel et al, 2020, IJMS CrossRef
  101. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.
    Cuiyun Li et al, 2018, Int J Mol Med CrossRef
  102. MicroRNA-124 suppresses growth and aggressiveness of osteosarcoma and inhibits TGF-β-mediated AKT/GSK-3β/SNAIL-1 signaling
    Yu Bo et al, 2018, Mol Med Report CrossRef
  103. Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma
    Yu‑Xin Liao et al, 2019, Int J Oncol CrossRef
  104. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Jiexiang Yang et al, 0 CrossRef
  105. Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway
    Yi‑Jiong Li et al, 2017, Exp Ther Med CrossRef
  106. Plasma-stimulated medium kills TRAIL-resistant human malignant cells by promoting caspase-independent cell death via membrane potential and calcium dynamics modulation
    Tomohiko Tokunaga et al, 2018, Int J Oncol CrossRef
  107. Identification of biomarkers associated with the recurrence of osteosarcoma using ceRNA regulatory network analysis
    Shanyong Zhang et al, 2019, Int J Mol Med CrossRef
  108. MicroRNA-18a inhibits cell growth and induces apoptosis in osteosarcoma by targeting MED27
    Jing Ding et al, 2018, Int J Oncol CrossRef
  109. Necrosis of osteosarcoma cells induces the production and release of high-mobility group box 1 protein.
    Jiyu Yang et al, 2018, Exp Ther Med CrossRef
  110. β‑elemene enhances anticancer bone neoplasms efficacy of paclitaxel through regulation of GPR124 in bone neoplasms cells
    Zongze Wang et al, 2018, Oncol Lett CrossRef
  111. Targeted MEK inhibition by cobimetinib enhances doxorubicin’s efficacy in osteosarcoma models
    Liang Ma et al, 2020, Biochemical and Biophysical Research Communications CrossRef
  112. Pseudogene MSTO2P enhances hypoxia-induced osteosarcoma malignancy by upregulating PD-L1
    Ce Shi et al, 2020, Biochemical and Biophysical Research Communications CrossRef
  113. LncRNA ADAMTS9-AS2 in osteosarcoma inhibits cell proliferation and enhances paclitaxel sensitivity by suppressing microRNA-130a-5p
    Xiaoqiang Ren et al, 2020, Eur J Inflamm CrossRef
  114. Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma
    Pankita H. Pandya et al, 2020, Cancers CrossRef
  115. Flavonoid compound breviscapine suppresses human osteosarcoma Saos‐2 progression property and induces apoptosis by regulating mitochondria‐dependent pathway
    Zhijun Wang et al, 2020, J Biochem Mol Toxicol CrossRef
  116. Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors.
    Shuichi Fujiwara et al, 2020, Stem Cell Res Ther CrossRef
  117. LncRNA KRAL suppresses cell growth and increases sensitivity to doxorubicin in osteosarcoma cells by sponging microRNAs-141
    Jingwei Cai et al, 2020, Eur J Inflamm CrossRef
  118. Pioglitazone modulates doxorubicin resistance in a in vivo model of drug resistant osteosarcoma xenograft
    Aparna Natarajan et al, 2020, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  119. A Correlation Between Intracellular Zinc Content and Osteosarcoma
    Azadeh Meshkini, 2020, Biol Trace Elem Res CrossRef
  120. A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma
    Jason A. Somarelli et al, 2020, Cancers CrossRef
  121. Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy
    Jordon M. Inkol et al, 2020, Vet Comp Oncol CrossRef
  122. Eldecalcitol induces apoptosis and autophagy in human osteosarcoma MG-63 cells by accumulating ROS to suppress the PI3K/Akt/mTOR signaling pathway
    Chaotao Zhang et al, 2020, Cellular Signalling CrossRef
  123. Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma
    Zhen-bin Diao et al, 2020, J Int Med Res CrossRef
  124. Targeting Super-Enhancer–Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor
    Jiajun Zhang et al, 2020, Clin Cancer Res CrossRef
  125. Recent Insights into Therapy Resistance in Osteosarcoma
    Zachary D. Prudowsky et al, 2020, Cancers CrossRef
  126. Non-Rodent Animal Models of Osteosarcoma: A Review
    Sommer Jarvis et al, 2021, Cancer Treatment and Research Communications CrossRef
  127. Sensitivity of Osteosarcoma Cells to Concentration-Dependent Bioactivities of Lipid Peroxidation Product 4-Hydroxynonenal Depend on Their Level of Differentiation
    Suzana Borovic Sunjic et al, 2021, Cells CrossRef
  128. Overexpression of miR‐329‐3p sensitizes osteosarcoma cells to cisplatin through suppression of glucose metabolism by targeting LDHA
    Gang Li et al, 2021, Cell Biol Int CrossRef
  129. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
    Louise Marchandet et al, 2021, Cancers CrossRef
  130. The LINC01410/miR-122-5p/NDRG3 axis is involved in the proliferation and migration of osteosarcoma cells.
    Weiguo Ma et al, 2021, IUBMB Life CrossRef
  131. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.
    Jun Wan et al, 2021, Cancer Sci CrossRef
  132. Transcription factor ELK1 accelerates aerobic glycolysis to enhance osteosarcoma chemoresistance through miR-134/PTBP1 signaling cascade
    Qiang Zhang et al, 2021, Aging CrossRef
  133. Prothymosin α promotes colorectal carcinoma chemoresistance through inducing lipid droplet accumulation
    Long Jin et al, 2021, Mitochondrion CrossRef
  134. Circular RNA circPVT1 Contributes to Doxorubicin (DXR) Resistance of Osteosarcoma Cells by Regulating TRIAP1 via miR-137
    Dan Li et al, 2021, BioMed Research International CrossRef
  135. Down‐regulation of circITCH promotes osteosarcoma development and resistance to doxorubicin via the miR‐524/RASSF6 axis
    Wei Zhou et al, 2021, J Gene Med CrossRef
  136. Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1
    Yan Zhao et al, 2021, Aging CrossRef
  137. Combination Therapy of Cisplatin and other Agents for Osteosarcoma: A Review
    Mohamad Z. Kasiram et al, 2021, CCTR CrossRef
  138. Effect of the Notch1-mediated PI3K-Akt-mTOR pathway in human osteosarcoma
    Kexiang Zhang et al, 2021, Aging CrossRef
  139. null
    Günther Richter et al, 2022 CrossRef
  140. Evaluation of the Chemotherapy Drug Response Using Organotypic Cultures of Osteosarcoma Tumours from Mice Models and Canine Patients
    Bénédicte Brulin et al, 2021, Cancers CrossRef
  141. Indocyanine Green for Leakage Control in Isolated Limb Perfusion
    Isabel Zucal et al, 2021, JPM CrossRef
  142. Chondroblastic Osteosarcoma of the Mandible in a Patient on Risedronate: A Rare Case of Neoadjuvant Chemotherapy Failure
    Soufiane Boussouni et al, 2021 CrossRef
  143. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway
    Peng Ji et al, 2015, oncol res CrossRef
  144. MicroRNA-20b Downregulates HIF-1α and Inhibits the Proliferation and Invasion of Osteosarcoma Cells
    Ming Liu et al, 2016, oncol res CrossRef
  145. The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis
    Chao Zhang et al, 2021, J Orthop Surg Res CrossRef
  146. Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma
    Xin Hu et al, 2022, Front. Oncol. CrossRef
  147. Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers
    Guillaume Anthony Odri et al, 2022, Cancers CrossRef
  148. Evaluation of the expression level of apoptosis and ferroptosis cell death pathways genes in patients with osteosarcoma
    Shima Nazem et al, 2022, Gene Reports CrossRef
  149. Falcarindiol Stimulates Apoptotic and Autophagic Cell Death to Attenuate Cell Proliferation, Cell Division, and Metastasis through the PI3K/AKT/mTOR/p70S6K Pathway in Human Oral Squamous Cell Carcinomas
    Kyung-Ran Park et al, 2022, Am. J. Chin. Med. CrossRef
  150. Bifunctional scaffolds for tumor therapy and bone regeneration: Synergistic effect and interplay between therapeutic agents and scaffold materials
    Jiongpeng Yuan et al, 2022, Materials Today Bio CrossRef
  151. Ginsenoside Rg5 Sensitizes Paclitaxel—Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel—And Enhances the Anticancer Effect of Paclitaxel
    Janani Ramesh et al, 2022, Genes CrossRef
  152. IGF2BP1-regulated expression of ERRα is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells
    Qing He et al, 2022, J Transl Med CrossRef
  153. Comparison of Selected Non-Coding RNAs and Gene Expression Profiles between Common Osteosarcoma Cell Lines
    Mateusz Sikora et al, 2022, Cancers CrossRef
  154. Nano/micro-formulations of keratin in biocomposites, wound healing and drug delivery systems; recent advances in biomedical applications
    Swati Sharma et al, 2022, European Polymer Journal CrossRef
  155. Induced resistance to ifosfamide in osteosarcoma cells suggests a more aggressive tumor profile
    Maria Tereza de Oliveira Rodrigues et al, 2022, Biochemistry and Biophysics Reports CrossRef
  156. CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer
    Ke-Da Yang et al, 2022, Mol Cell Biochem CrossRef
  157. Noncoding RNA PVT1 in osteosarcoma: The roles of lncRNA PVT1 and circPVT1
    Tingrui Wu et al, 2022, Cell Death Discov. CrossRef
  158. Effect of different solvents on nisin ZP potential as anticancer agent against MG-63 osteosarcoma cells
    Muhammad Fairuz Azmi et al, 2022, APJMBB CrossRef
  159. LAMTOR5-AS1 regulates chemotherapy-induced oxidative stress by controlling the expression level and transcriptional activity of NRF2 in osteosarcoma cells
    Youguang Pu et al, 2021, Cell Death Dis CrossRef
  160. Targeting RNA Polymerase I Transcription Activity in Osteosarcoma: Pre-Clinical Molecular and Animal Treatment Studies
    Chang-Won Kang et al, 2023, Biomedicines CrossRef
  161. Biomaterial-assisted tumor therapy: A brief review of hydroxyapatite nanoparticles and its composites used in bone tumors therapy
    Quan Zhang et al, 2023, Front. Bioeng. Biotechnol. CrossRef
  162. Induced Resistance to Ifosfamide in Osteosarcoma Cells Suggests a More Aggressive Tumor Profile
    Maria Tereza de Oliveira Rodrigues¹ et al, 2022, SSRN Journal CrossRef
  163. Localized Nanoparticle‐Mediated Delivery of miR‐29b Normalizes the Dysregulation of Bone Homeostasis Caused by Osteosarcoma whilst Simultaneously Inhibiting Tumor Growth
    Fiona E. Freeman et al, 2023, Advanced Materials CrossRef
  164. Protective effects of polydatin against bone and joint disorders: the in vitro and in vivo evidence so far
    Zhen Zhang et al, 2023, Nutr. Res. Rev. CrossRef
  165. A glycometabolic gene signature associating with immune infiltration and chemosensitivity and predicting the prognosis of patients with osteosarcoma
    Fengyan Wang et al, 2023, Front. Med. CrossRef
  166. PLGA-based drug delivery systems in treating bone tumors
    Enduo Qiu et al, 2023, Front. Bioeng. Biotechnol. CrossRef
  167. Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
    Yubo Xiang et al, 2023, Front. Oncol. CrossRef
  168. Cisplatin and doxorubicin chemotherapy alters gut microbiota in a murine osteosarcoma model
    Zhi Tian et al, 2024, Aging CrossRef
  169. Combination Treatment with Liposomal Doxorubicin and Inductive Moderate Hyperthermia for Sarcoma Saos-2 Cells
    Valerii E. Orel et al, 2024, Pharmaceuticals CrossRef
  170. Microvessel Density (MVD) in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis
    Konstantinos Perivoliotis et al, 2024, Cancer Investigation CrossRef